Search hospitals > South Carolina > Greenville

Prisma Health Greenville Memorial Hospital

Claim this profile
Greenville, South Carolina 29605
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
424 reported clinical trials
38 medical researchers
Photo of Prisma Health Greenville Memorial Hospital in GreenvillePhoto of Prisma Health Greenville Memorial Hospital in GreenvillePhoto of Prisma Health Greenville Memorial Hospital in Greenville

Summary

Prisma Health Greenville Memorial Hospital is a medical facility located in Greenville, South Carolina. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Prisma Health Greenville Memorial Hospital is involved with conducting 424 clinical trials across 736 conditions. There are 38 research doctors associated with this hospital, such as Ki Chung, MD, Aniket Saha, Jeffrey K. Giguere, and Michael J Wagner, MD.

Area of expertise

1Lung Cancer
Global Leader
Prisma Health Greenville Memorial Hospital has run 52 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Cancer
Global Leader
Prisma Health Greenville Memorial Hospital has run 47 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Prisma Health Greenville Memorial Hospital

Lung Cancer
Bladder Cancer
Breast Cancer
Cancer
Ovarian Cancer
Breast cancer
Prostate Cancer
Stroke
Heart Failure
Pancreatic Cancer
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Ivonescimab + Pembrolizumab

for Lung Cancer

This trial is testing two treatments for advanced lung cancer. One uses a new drug, Ivonescimab, and the other uses an existing drug, Pembrolizumab, both combined with chemotherapy. The goal is to see which treatment helps patients live longer and has fewer side effects.
Recruiting2 awards Phase 38 criteria
Image of trial facility.

Targeted Drug Therapy

for Non-Small Cell Lung Cancer

This phase II Lung-MAP treatment trial test the combination of targeted drugs (capmatinib, osimertinib, and/or ramucirumab) in treating patients with non-small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and that has EGFR and MET gene changes. Capmatinib and osimertinib are in a class of medications called kinase inhibitors. They work by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells and may help shrink tumors. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Giving capmatinib, osimertinib, and/or ramucirumab and targeting abnormal gene changes in tumor cells may be effective in shrinking or stabilizing advanced non-small cell lung cancer.
Recruiting1 award Phase 228 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Prisma Health Greenville Memorial Hospital?
Where is Prisma Health Greenville Memorial Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Prisma Health Greenville Memorial Hospital accept?
What awards or recognition has Prisma Health Greenville Memorial Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security